MindMaze Therapeutics Holding SA develops and operates the MindMaze platform that integrates neuroscience and digital therapeutics to address some of the most pressing challenges in neurology. MindMaze Therapeutics Holding SA was formerly known as NeuroX Group SA. The company was incorporated in 2025 and is based in Lausanne, Switzerland. Show more
Chemin de Roseneck 5, Lausanne, 1006, Switzerland
Start AI Chat
Market Cap
17.01M
52 Wk Range
$1.20 - $4.88
Previous Close
$1.35
Open
$1.35
Volume
89
Day Range
$1.35 - $1.35
Enterprise Value
34.19M
Cash
12.5M
Avg Qtr Burn
N/A
Insider Ownership
33.45%
Institutional Own.
25.68%
Qtr Updated
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
RLF-TD011 (APR-TD011) Details Epidermolysis bullosa | Phase 1 Update |